EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Immunoaging at Early Ages Could Drive a Higher Comorbidity Burden in People with HIV on Antiretroviral Therapy Compared with the Uninfected Population

Cora Loste, Macedonia Trigueros, Francisco Muñoz-López, Víctor Urrea iD, Ana Martínez, Sandra González, Jordi Puig iD, Marta Martín, Anna Bonjoch iD, Patricia Echeverría, Marta Massanella iD, Eugenia Negredo

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252010930 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Cora Loste und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, University Hospital Germans Trias i Pujol, Campus Can Ruti, 08916 Barcelona, Spain. Hauptthemen laut MEDLINE: HIV Infections, Comorbidity, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was funded by the Spanish Health Institute Carlos III (Grant PI19/00947 to EN) and the Spanish Ministry of Science and Innovation (grant PID2020-1149…, Spanish Health Institute Carlos III, Spanish Ministry of Science and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This is an observational, cross-sectional, comparative case–control, pilot study aimed at assessing the impact of HIV infection and age on immunological markers in people with HIV (PWH) on antiretroviral therapy (ART). The study included 40 PWH on ART, divided into two age groups (40–45 years vs. ≥60 years), and 30 HIV-uninfected controls matched by sex and age. The results show that older PWH on ART had more comorbidities and a higher frequency of CD8 T cells compared to older controls, with a significant decrease in CD8 naïve T cells with age. Additionally, younger PWH on ART exhibited higher frequencies of activated CD8 T cells and elevated levels of inflammatory markers (sCD14, IL-6) compared to age-matched controls, with values similar to those of older PWH on ART. These findings suggest that younger PWH on ART may experience accelerated immunoaging, highlighting the need for early interventions in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsComorbidityCD8-Positive T-LymphocytesHumansMaleMiddle AgedFemaleAdultCase-Control StudiesCross-Sectional StudiesPilot ProjectsAnti-Retroviral AgentsAge FactorsAgingAgedBiomarkers

Stichwörter der Autor:innen

HIVaginginflammaging

Substanzen

Anti-Retroviral AgentsBiomarkers

Autor:innen und Institutionen

  • Department of Infectious Diseases, University Hospital Germans Trias i Pujol, Campus Can Ruti, 08916 Barcelona, Spain.
  • Fight Against Infections Foundation, Campus Can Ruti, 08916 Badalona, Spain.
  • Chair in Infectious Diseases and Immunity, Centre for Health and Social Care Research (CESS), Faculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain.
  • PhD Programme in Medicine and Biomedical Sciences, Doctoral School, University of Vic-Central University of Catalonia (UVic-UCC), C. Dr. Junyent, 1, 08500 Vic, Spain.
  • IrsiCaixa, 08916 Badalona, Spain.
  • Department of Medicine, Autonomous University of Barcelona, 08193 Barcelona, Spain.

ORCID-Profile: Víctor Urrea, Jordi Puig, Anna Bonjoch, Marta Massanella

Förderung

  • This work was funded by the Spanish Health Institute Carlos III (Grant PI19/00947 to EN) and the Spanish Ministry of Science and Innovation (grant PID2020-1149…
  • Spanish Health Institute Carlos III
  • Spanish Ministry of Science and Innovation
  • Departament de Salut from Generalitat de Catalunya
  • Sorigué Foundation
  • Spanish Ministry of Science and Innovation and the State Research Agency
  • European Social Fund “investing in your future”

Zitieren

APA

Loste, C., Trigueros, M., Muñoz-López, F., Urrea, V., Martínez, A., González, S., Puig, J., Martín, M., Bonjoch, A., Echeverría, P., Massanella, M., & Negredo, E. (2024). Immunoaging at Early Ages Could Drive a Higher Comorbidity Burden in People with HIV on Antiretroviral Therapy Compared with the Uninfected Population. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252010930

Vancouver

Loste C, Trigueros M, Muñoz-López F, Urrea V, Martínez A, González S, et al. Immunoaging at Early Ages Could Drive a Higher Comorbidity Burden in People with HIV on Antiretroviral Therapy Compared with the Uninfected Population. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252010930

BibTeX
@article{Loste2024,
  author = {Loste, Cora and Trigueros, Macedonia and Muñoz-López, Francisco and Urrea, Víctor and Martínez, Ana and González, Sandra and Puig, Jordi and Martín, Marta and Bonjoch, Anna and Echeverría, Patricia and Massanella, Marta and Negredo, Eugenia},
  title = {Immunoaging at Early Ages Could Drive a Higher Comorbidity Burden in People with HIV on Antiretroviral Therapy Compared with the Uninfected Population},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252010930}
}
Kostenlos starten →